
United States · Public relations & communications startup
Affect Therapeutics is a digital health company based in McLean, Virginia, focused on providing app-based treatment for mental health and substance use disorders.
Funding reportedLast round: Series B
Affect Therapeutics is a digital health company based in McLean, Virginia, focused on providing app-based treatment for mental health and substance use disorders.
Founded in 2020, it is the only nationally scaled digital treatment provider in the U.S. that serves individuals across all types of insurance. The company utilizes contingency management and advanced behavioral science to engage high-need patients in care. The primary offering is a smartphone app available for free on both the Apple App Store and Google Play. This app delivers evidence-based, substance-specific recovery programs for disorders such as alcohol and methamphetamine addiction. It combines financial incentives, therapy, and medication to support individuals in overcoming their addictions. Affect Therapeutics also provides online therapy and psychiatric services through the app, targeting adults with substance use disorders and mental health conditions. The company has secured significant funding, raising $16 million in Series A funding in 2023 and $26 million in Series B funding in 2025.
Funding, as reported
From Affect (Acquired by Gregory FCA)'s own website: 6 on the team.
What they build
Known for
public relations & communications serviceshospital & health carehealth careprivate and confidentialremote treatmentaddiction treatmenthipaa complianttherapy and counselingmental wellness toolsconsumerscontingency management rewardssubstance use disordersmental health conditionsdigital health incentivesbehavioral health trackingmarketing
Built with from their website
Amazon Elastic MapReduceGoogleWP EngineAmazon Route 53Microsoft OfficeGoogle Search ConsoleAWS CloudAmazon AWSWordpressMySQL
Cornerstone HRRECGoogle WorkspaceElectronGoogle MeetPHPSemrushGmail
Add your raise, your deck and your story, and put Affect (Acquired by Gregory FCA) in front of investors. Or tell us what we have wrong.